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UltraViolet (UV) spectroscopy was evaluated as an innovative Process Analytical 2 
Technology (PAT) - tool for the in-line and real-time quantitative determination of low-3 
dosed active pharmaceutical ingredients (APIs) in a semi-solid (gel) and a liquid 4 
(suspension) pharmaceutical formulation during their batch production process. The 5 
performance of this new PAT-tool (i.e., UV spectroscopy) was compared with an already 6 
more established PAT-method based on Raman spectroscopy. In-line UV measurements 7 
were carried out with an immersion probe while for the Raman measurements a non-8 
contact PhAT probe was used. For both studied formulations, an in-line API quantification 9 
model was developed and validated per spectroscopic technique. The known API 10 
concentrations (Y) were correlated with the corresponding in-line collected preprocessed 11 
spectra (X) through a Partial Least Squares (PLS) regression. Each developed 12 
quantification method was validated by calculating the accuracy profile on the basis of the 13 
validation experiments. Furthermore, the measurement uncertainty was determined 14 
based on the data generated for the determination of the accuracy profiles. From the 15 
accuracy profile of the UV- and Raman-based quantification method for the gel, it was 16 
concluded that at the target API concentration of 2 % (w/w), 95 out of 100 future routine 17 
measurements given by the Raman method will not deviate more than 10 % (relative error) 18 
from the true API concentration, whereas for the UV method the acceptance limits of 10 19 
% were exceeded. For the liquid formulation, the Raman method was not able to quantify 20 
the API in the low-dosed suspension (0.09 % (w/w) API). In contrast, the in-line UV method 21 
was able to adequately quantify the API in the suspension. This study demonstrated that 22 




quantification purposes in pharmaceutical processes. Important is that none of the two 24 
spectroscopic techniques was superior to the other for both formulations: the Raman 25 
method was more accurate in quantifying the API in the gel (2 % (w/w) API), while the UV 26 
method performed better for API quantification in the suspension (0.09 % (w/w) API). 27 
Keywords 28 
In-line UV spectroscopy, In-line Raman spectroscopy, Semi-solids, Liquids, Process 29 
Analytical Technology (PAT), Accuracy profile. 30 
1. INTRODUCTION 31 
Spectroscopic techniques are increasingly proposed as alternative methods for the 32 
quantification of APIs in pharmaceuticals. This is due to their advantages over the 33 
traditional techniques, such as fast, in-line, non-invasive and non-destructive 34 
measurements without the need of sample preparation. Near infrared (NIR) and Raman 35 
spectroscopy have been identified as effective PAT-tools for real-time measurements of 36 
critical process and product attributes during pharmaceutical processing. Raman 37 
spectroscopy is until now mostly applied for solid dosage forms [1]–[6]. Some in-line 38 
quantitative applications for hot-melt extrusion processes have also been reported [7]–[9]. 39 
Raman spectroscopy has an added value for quantification purposes of pharmaceutical 40 
formulations where water is present, such as in semi-solid and liquid formulations, since 41 
water produces almost no Raman signal. Research has already been conducted to 42 
investigate the opportunity offered by Raman spectroscopy for these formulations [10]–43 
[15], however less frequently as an in-line analytical tool [16]. For some applications, these 44 




low-dosed analytes. Fluorescence spectroscopy can be an alternative to the conventional 46 
spectroscopic techniques for these applications because of its high sensitivity and 47 
detection sensitivity [17], [18]. A drawback of fluorescence spectroscopy is that the analyte 48 
needs to be a native fluorophore in order to detect it, which limits the number of possible 49 
applications for this technique [19]. 50 
UV spectroscopy is a widely used quantitative analytical technique that finds its 51 
application in many research domains and is capable of quantifying very low 52 
concentrations (< 0.01 %) [20]–[24]. Nevertheless, studies describing on-line and in-line 53 
applications of UV/VIS spectroscopy with fibre-optic probes are limited. O’Keeffe et al. 54 
monitored the ozone concentration of a gas in an aluminium glass cell with a fibre-based 55 
UV/VIS spectroscopy system [25]. Quinn et al. followed the reaction of a nucleoside with 56 
trityl chloride in pyridine in a liquid environment [26], using a fibre-optic transmission 57 
probe. The concentration of starting material and product was predicted via a PLS 58 
regression model. Furthermore, a mixing study using a fibre-optic UV/VIS monitoring 59 
technique was reported by Ng and Assirelli [27]. In this paper, bromophenol blue sodium 60 
salt was used as a non-reactive tracer in distilled water. A good agreement between the 61 
UV/VIS technique and the traditional conductivity technique was found. Other examples 62 
of on-line and in-line UV spectroscopic applications in literature are drug dissolution tests, 63 
where the drug release was monitored in real-time [24], [28]. However, the use of UV 64 
spectroscopy for in-line monitoring of critical quality attributes during pharmaceutical 65 
manufacturing processes of semi-solids and liquids is not yet described in literature. 66 
In this study, UV spectroscopy was evaluated as a new PAT-tool for the in-line and real-67 




solid and liquid formulations. Furthermore, the performance of this new PAT-tool was 69 
compared with an already established and widely adopted PAT-method based on Raman 70 
spectroscopy. The in-line UV spectroscopic measurements were carried out by an 71 
immersion probe. For the in-line Raman measurements, a PhAT probe was used. This 72 
type of Raman probe was until now only applied in pharmaceutical unit operations such 73 
as milling, blending and coating of solid dosage forms [29]. A pharmaceutical gel and 74 
suspension with an API concentration of 2 and 0.09 % (w/w), respectively, were selected 75 
as model formulations. For both formulations, a PLS regression model was developed per 76 
spectroscopic technique and the quantification abilities of both techniques were 77 
compared. The validation of the calibration models was assessed via accuracy profiles, a 78 
validation strategy for quantitative analytical procedures proposed by the Société 79 
Francaise des Sciences et Techniques Pharmaceutiques (SFSTP) [30]–[32]. 80 
2. MATERIALS AND METHODS 81 
2.1. Materials 82 
Commercially available pharmaceutical formulations were kindly provided by Janssen 83 
Pharmaceutica (Beerse, Belgium): a semi-solid (gel) and a liquid (suspension), having an 84 
API target concentration of 2 % and 0.09 % (w/w), respectively. Laboratory-scale batches 85 
of the formulations were manufactured based on confidential information provided by 86 
Janssen Pharmaceutica.  87 
2.2. Methods 88 




All formulations were produced with a customized IKA LR2000 mixing system (IKA, 90 
Staufen, Germany). The mixing vessel was equipped with a heated jacket for controlling 91 
the temperature of the process using a water bath (Type 1032, GFL, Burgwedel, 92 
Germany). Interface openings were provided in the cover of the mixing vessel for the 93 
implementation of the UV and Raman probe (figure 1). 94 
2.2.2. Calibration and validation samples 95 
In total, one calibration batch and three validation batches were produced for each 96 
formulation. Validation batch one and three were produced by operator A and validation 97 
batch two by operator B. Also, the validation batches were produced on three different 98 
days. Instead of producing a complete batch for each concentration level of the calibration 99 
(80, 90, 95, 100, 105, 110 and 120 % relative to target) and validation (85, 95, 100, 105 100 
and 115 % relative to target) set, all the concentration levels were created using one 101 
calibration batch and three validation batches (three different days). This was done by the 102 
stepwise addition of API to a batch, corresponding to the different concentration levels. 103 
The calibration batch was produced following the standard batch production procedure of 104 
the formulations. However, instead of producing a batch with the target API concentration 105 
(i.e., 100 % of target), the calibration batch contained only 80 % of the target API 106 
concentration. After completing batch manufacturing, spectra of the lowest concentration 107 
level (i.e., 80 % of target) were collected in-line while the formulation was being mixed. 108 
Next, a specific amount of API was added to the calibration batch, corresponding to the 109 
subsequent concentration level (i.e., 90 % of target), followed by the collection of spectra. 110 
These steps (i.e., API addition and spectra recording) were repeated until the highest 111 




spectra were recorded at each concentration. The validation batches were produced 113 
following the same procedure as described for the calibration batch, but with other 114 
concentration levels (85, 95, 100, 105 and 115 % relative to target). During this procedure 115 
(i.e., API addition and spectra recording), the formulation was mixed with a constant 116 
mixing speed.  117 
2.2.3. UV spectroscopy  118 
An Avaspec-ULS2048L spectrometer (Avantes, Apeldoorn, The Netherlands), equipped 119 
with a CCD detector, was connected by a fibre-optic cable to an immersion probe with a 120 
45 degree angle window. The probe contained six illumination fibres and one detection 121 
fibre. The light source was an AvaLight Deuterium-Halogen Lamp. All spectra were 122 
acquired in the 200 - 1100 nm spectral range. The exposure time was 1000 ms and 950 123 
ms for the gel and suspension, respectively, with each spectrum the average of 5 scans 124 
and a total of 40 spectra/concentration level. The immersion probe was inserted via the 125 
cover of the mixing vessel through a custom made interface (figure 1b). 126 
2.2.4. Raman spectroscopy  127 
In-line Raman spectra were recorded using a Raman Rxn2 spectrometer (Kaiser Optical 128 
Systems, Ann Arbor, MI, USA), equipped with a CCD detector and a fibre-optic PhAT 129 
probe. The laser wavelength was 785 nm with a laser power of 400 mW. The spectral 130 
range of the system was 150 - 1890 cm-1 with a resolution of 5 cm-1. For all formulations 131 
an exposure time of 15 s with no averaging was used and every 30 s a spectrum was 132 
recorded. Per concentration level, 30 spectra were collected in-line for both the calibration 133 




cover of the mixing vessel and fixed with a sealing to ensure a fixed probe position (figure 135 
1c). 136 
2.2.5. Development of the calibration models 137 
For each formulation one calibration model per spectroscopic technique was developed 138 
(table 1). The UV calibration model of the gel was developed applying mean-centering, 139 
Standard Normal Variate (SNV) correction and first-derivative transformation as 140 
preprocessing methods in combination with selecting the spectral region between 280 - 141 
297 nm (table 1). The Raman spectra of the gel were mean-centered and SNV corrected, 142 
followed by taking the first derivative and selecting the spectral regions where the API 143 
showed Raman activity. SNV preprocessing was applied to eliminate baseline offset 144 
variations, which can be caused by scatter differences between the samples. First 145 
derivative transformation allowed a better visualization of small absorption bands and 146 
corrected for baseline shifts [33]. 147 
The API concentrations (Y) were regressed against the corresponding in-line collected 148 
preprocessed spectra (X) through a PLS method. The goodness of fit and the predictive 149 
ability of the developed PLS models were assessed by the calculation of R2 and Q2, 150 
respectively. Q2 values were obtained after performing a leave-one-out cross-validation, 151 
in which sub-models were developed from a reduced calibration dataset and the excluded 152 
data was predicted by the sub-models. The number of PLS components providing the 153 
highest Q2 value was selected. Details of the developed UV and Raman PLS models of 154 
the suspension are also displayed in table 1. The PLS models were created using the 155 




2.2.6. Validation of the calibration models 157 
The predictive properties of the developed models were first assessed by computation of 158 
the Root Mean Square Error of Prediction (RMSEP), obtained when predicting the 159 
external validation sets. During validation, the within-day, between-day and operator 160 
variability were incorporated. Accuracy profiles were adopted to evaluate the validation of 161 
the developed analytical methods and are proposed by SFSTP as a harmonized approach 162 
for the validation of quantitative analytical procedures [30]–[32]. The objective of validation 163 
is to ensure that the difference between the measured value (xi) and the unknown true 164 
value of the sample (μT) will be lower than an acceptance limit (λ): 165 
|𝑥𝑖  −  µ𝑇| < 𝜆    (1) 166 
Here, λ was set at 10 %. For an analytical method to be considered as acceptable, it must 167 
be assured that the probability that a measurement will fall outside the acceptance limits 168 
is less than or equal to the maximum risk that the analyst is able to take during routine 169 
use: 170 
Pr(|𝑥𝑖  −  µ𝑇| < 𝜆) ≥ 𝛽    (2) 171 
The desired proportion of measurements inside the acceptance limits (β) was set at 95 172 
%. The computation of a large number of validation parameters (e.g., precision, trueness, 173 
linearity, …) is not sufficient to decide whether the objectives of validation are ensured. 174 
Therefore, the accuracy profile was used as a decision tool for the validity of the analytical 175 
methods, which is constructed from the total error of the method, being the sum of the 176 




repeatability (within-day variability) and intermediate precision (between-day and operator 178 
variability) were calculated [34]. In the accuracy profiles, the acceptance limits are plotted 179 
together with the relative error of the individual predictions, the relative bias and the β-180 
expectation tolerance intervals at each concentration level of the validation set. Here, the 181 
acceptance limits were set at 10 % relative error. The β-expectation tolerance intervals 182 
visualise at each concentration level where at least 95 out of 100 future measurements 183 
given by the analytical procedure will fall between [35]. The intersect between the 184 
acceptance limits and the β-expectation tolerance intervals defines the upper and lower 185 
quantification limits of the analytical method. The accuracy profiles were calculated from 186 
the data obtained from the validation experiments. 187 
Furthermore, the standard deviation of the β-expectation tolerance intervals was used for 188 
the estimation of the standard uncertainty in the measurements [36]. The uncertainty is 189 
defined as a parameter associated with the result of a measurement, that characterises 190 
the dispersion of the values that could reasonably be attributed to the measurand. The 191 
measurement uncertainty was expressed by four uncertainty parameters: uncertainty of 192 
the bias, uncertainty (combination of uncertainty of the bias with the intermediate precision 193 
standard deviation), expanded uncertainty and the relative expanded uncertainty. The 194 
expanded uncertainty represents an interval around the mean value where the unknown 195 
true value can be located with a certain confidence level (here 95 %). The relative 196 
expanded uncertainty is calculated as the expanded uncertainty divided by the 197 
corresponding true concentration [37]. 198 




The development and validation of the PLS models for the gel formulation, based on the 200 
measurements with the two spectroscopic techniques (UV and Raman spectroscopy), will 201 
be discussed in detail in the results section. Information regarding the development and 202 
validation of the PLS models of the suspension can be found in tables 1, 2, 3 and 4. 203 
3.1. Development of the calibration models 204 
3.1.1. UV spectroscopy 205 
The in-line UV/VIS measurements were made in the 200 - 1100 nm spectral range. Only 206 
the UV region (200 - 400 nm) was investigated, since the size of the conjugated system 207 
of the API was not large enough to absorb in the VIS region [38]. Also, prominent 208 
deuterium peaks were present in the VIS region (486 and 656 nm), which were not of 209 
interest [39]. In a first step, the molecular structure of the API in the gel was screened for 210 
UV activity. Several aromatic groups were found in the molecular structure and suggested 211 
that the API will absorb in the UV region. The exact absorption wavelength is dependent 212 
of the type and number of functional groups coupled to the aromatic rings, which can shift 213 
the absorption wavelength to lower or higher wavelengths [38]. To confirm whether the 214 
API could indeed be detected in the UV spectra of the gel, where possible interfering 215 
components are present, the spectra of the calibration batch were coloured according to 216 
concentration level and it was checked whether the colours were in sequence with the 217 
concentration levels. A distinctive peak in the region 280 - 297 nm was observed in the 218 
SNV-corrected and first-derived UV spectra of the gel, where the spectra were clearly 219 




A PLS model was developed from the mean-centered, SNV-corrected and first-derived 221 
UV spectra of the gel between 280 - 297 nm (R2 = 0.988; Q2 = 0.988; Root Mean Square 222 
Error of Cross Validation (RMSECV) = 0.0274 % w/w) (table 1 and 2). Selecting this 223 
spectral region eliminated interfering variance sources, thereby increasing the variance 224 
due to concentration differences. RMSEP values (0.0584, 0.0709 and 0.0588 % w/w) of 225 
the gel were calculated from the predictions of the three validation batches. Also for the 226 
suspension a calibration model was developed, following the same strategy as described 227 
for the gel (table 1 and 2). 228 
3.1.2. Raman spectroscopy 229 
The Raman spectra of the gel formulation (calibration batch) and pure API are presented 230 
in figure 3. The peaks in the spectra of the pure API with the highest intensity are situated 231 
around 396, 660, 1348 and 1590 cm-1. It can be noticed from figure 3 that at these Raman 232 
shifts, peaks in the spectra of the gel are visible. A detail of the preprocessed spectra of 233 
the gel calibration set at the above mentioned spectral regions is shown in figure 4. 234 
Applying these preprocessing methods highlighted the spectral differences most. A logic 235 
concentration trend in the spectra was observed at the API selective bands: increasing 236 
Raman intensity for an increasing API concentration. These four regions were the most 237 
abundant peaks in the Raman spectra of the pure API (figure 3), suggesting that the trend 238 
in the spectra was caused by the difference in API concentration. 239 
The model of the gel formulation with the highest predictive performance (R2 = 0.973; Q2 240 
= 0.973; RMSECV = 0.0418 % w/w) was created from the mean-centered, SNV corrected 241 




1570 - 1600 cm-1 (table 1). The selection of these spectral regions was based on the 243 
evaluation of the Raman spectra of the pure API and gel (figure 3 and 4). The resulting 244 
RMSEP values of the three validation sets were 0.0255, 0.0235 and 0.0381 % (w/w). The 245 
PLS model of the suspension, measured with the Raman PhAT probe, was constructed 246 
using the same strategy as described above and detailed information regarding the 247 
construction of the model together with the resulting RMSECV and RMSEP values can 248 
be found in table 1 and 2. 249 
  250 
3.2. Validation of the calibration models 251 
3.2.1. UV spectroscopy 252 
The accuracy profile for the UV-based in-line quantification method of the gel is displayed 253 
in figure 5a. At each validation concentration level, the β-expectation tolerance intervals 254 
exceeded the acceptance limits (10 % relative error) (figure 5a). Furthermore, the 255 
predictions of the lowest API concentration level (1.75 % w/w) were more biased than the 256 
other concentration levels (table 3). This is probably because of the difficulty to detect this 257 
low API concentration. The calculated precision parameters (repeatability and 258 
intermediate precision) from the UV-based in-line quantification method showed that the 259 
intermediate precision Relative Standard Deviation (RSD) was much higher compared to 260 
the repeatability RSD at all concentration levels (table 3). Because of the lower 261 
intermediate precision, an important day or operator effect was causing variability in the 262 
predictions. 263 
The accuracy profile of the UV-based in-line quantification method of the suspension is 264 




the β-expectation tolerance intervals fell within the acceptance limits of 10 % (relative 266 
error). Therefore, future measurements between an API concentration of 0.0865 and 267 
0.0955 % (w/w) obtained by this procedure have a probability of 95 % that the difference 268 
between the measured concentration and the true concentration is less than 10 % (relative 269 
error). However, the β-expectation tolerance intervals at the lowest (0.0774 % w/w) and 270 
highest (0.1046 % w/w) API concentration level were almost exceeding the 20 % (relative 271 
error) acceptance limits. The relative bias at API concentration level 0.0774 and 0.1046 272 
% (w/w) was 3.04 and -4.05 %, respectively. This value is remarkably higher than the 273 
relative bias (1.40, 0.65 and -0.92 %) of the other validation concentration levels. 274 
Furthermore, a higher imprecision for the lowest and highest concentration level was 275 
observed, which was mainly induced by a low intermediate precision, suggesting an 276 
important day or operator effect. Table 2 shows that the RMSEP of day 1 (0.00496 % w/w) 277 
was almost four times higher than the RMSEP of day 2 (0.00148 % w/w) and 3 (0.00171 278 
% w/w). A cause for the less accurate predictions of the day 1 validation samples was not 279 
found, but could be operator related such as an accidental alteration in the production 280 
process of these validation samples. 281 
3.2.2. Raman spectroscopy 282 
For the accuracy profile of the Raman-based in-line quantification method of the gel, the 283 
β-expectation tolerance intervals exceeded the 10 % (relative error) acceptance limits only 284 
at the 1.75 % (w/w) API concentration level (figure 5b). Hence, in the 1.96 - 2.37 % (w/w) 285 
API concentration range, 95 out of 100 future measurements will be included within the 286 
acceptance limits of 10 % (relative error) and even within the 5 % (relative error) 287 




tolerance interval at the 1.75 % (w/w) API concentration level, the trueness and precision 289 
were investigated. The calculated relative bias and RSD for repeatability at this level were 290 
not higher than for the other concentration levels, but the intermediate precision RSD was 291 
higher (table 3). There was indeed one validation batch (day 3) where the predictions of 292 
the lowest concentration level were lower in comparison to the other validation batches. 293 
This variability could be caused by the detection sensitivity limitations of the Raman 294 
method at the lowest concentration level. 295 
The accuracy profile for the in-line Raman-based quantification method of the suspension 296 
was developed following the same strategy as described above and is displayed in figure 297 
6b. The β-expectation tolerance intervals exceeded the 10 % (relative error) acceptance 298 
limits over the whole concentration range, except for the API concentration levels 0.0862 299 
and 0.0953 % (w/w). The accuracy profile has a clear downward trend, i.e., low 300 
concentration levels were predicted higher, the intermediate concentration level was 301 
predicted around the target concentration and the high concentration levels were 302 
predicted lower. This demonstrated that all the concentration levels were predicted as the 303 
same value, indicating that the small changes in API concentration could not be detected 304 
and that the quantification of the low-dosed API in this suspension could not be achieved 305 
with Raman spectroscopy. 306 
When the accuracy profiles and validation parameters of the UV and Raman quantification 307 
methods of the suspension are compared, it is clear that the in-line quantification of the 308 
API only was possible with UV spectroscopy (table 2 and 3). To better understand the 309 
difference in predictive performance of both spectroscopic techniques, the in-line UV and 310 




spectra are clearly separated according to API concentration between 310 - 325 nm, 312 
which confirmed the quantification ability and high sensitivity of UV spectroscopy for this 313 
API. In the Raman spectra, no spectral differences between the concentration levels are 314 
seen and no API specific peaks can be located in the spectra of the suspension, despite 315 
investigating a region of the spectra where the API is Raman active. Increasing the 316 
exposure time and number of scans of the Raman spectrometer had no impact on the 317 
detection of the API. 318 
The high sensitivity of UV spectroscopy was correlated with the strong UV activity of the 319 
API in the suspension, due to conjugated double bonds in its molecular structure [38], 320 
[40]. However, the molecular structure of the API also meets to the requirements (non-321 
polar bonds and aromatic rings) for good Raman activity, suggesting that the failure of the 322 
Raman method for the suspension is linked to the inherent weak Raman effect [17], [41]. 323 
Raman spectroscopy applies monochromatic light to irradiate the samples and the 324 
incident light is scattered by the sample molecules. Most of this light is scattered at the 325 
same frequency, i.e., Raleigh radiation. Only one in 108 incident photons is scattered with 326 
a different frequency than the incident light (Raman effect). This in combination with the 327 
small fraction of light which is scattered into the same direction of the probe, explains why 328 
the quantification of low concentrations can be an issue for Raman spectroscopy [41]. 329 
UV spectroscopy was identified as a novel and alternative in-line spectroscopic tool for 330 
quantification purposes, in addition to the widely used Raman spectroscopy. Important is 331 
that none of the two spectroscopic techniques was superior to the other for both the 332 
formulations. While Raman was more accurate in quantifying the API in the gel (2 % w/w), 333 




based method. This study illustrated that spectroscopic techniques can be complementary 335 
and that the preferred technique is dependent on several factors such as the molecular 336 
structure of the API, concentration of the analyte, measurement conditions, presence of 337 
interfering components, measurement time and cost. In addition, the UV immersion probe 338 
was more practical to work with inside a process environment, because the probe tip can 339 
be in direct contact with the sample. Furthermore, UV spectroscopy is a suitable PAT-tool 340 
for measurements in aqueous environments, since the suspension contained water. This 341 
would be challenging for NIR spectroscopy because water creates strong absorbance 342 
peaks in the near infrared region, which can potentially overwhelm the signal(s) of the API 343 
[41]. Preliminary off-line experiments with NIR spectroscopy showed that the APIs had 344 
weak signals in the near infrared region and therefore NIR spectroscopy was not further 345 
investigated in this study. 346 
The measurement uncertainty of the UV- and Raman-based calibration models is 347 
summarized in table 4 in terms of the uncertainty of the bias, uncertainty, expanded 348 
uncertainty and the relative expanded uncertainty at each concentration level of the 349 
validation sets [36]. For the UV-based method of the suspension, the relative expanded 350 
uncertainty at the target API concentration (0.09 % w/w) was 3.82 % (relative error) (table 351 
4). This means that the unknown true value is located at a maximum of ± 3.82 % (relative 352 
error) around the measured value, with a confidence level of 95 %. In comparison, the 353 
relative expanded uncertainty at the target concentration of the suspension was 6.53 % 354 
(relative error) for the Raman-based method. 355 




In this study, analytical methods based on in-line UV spectroscopy were developed for 357 
the quantification of APIs in pharmaceutical semi-solid and liquid formulations. The 358 
performance of this new PAT-tool was compared with an already more established PAT-359 
method based on Raman spectroscopy. In-line UV measurements were carried out with 360 
an immersion probe while for the Raman measurements a PhAT probe was used. The 361 
validation of the analytical methods was evaluated by the calculation of accuracy profiles, 362 
ensuring that 95 out of 100 future routine measurements will be included within the present 363 
acceptance limits of 10 % (relative error). Furthermore, the uncertainty of bias and the 364 
expanded uncertainty were estimated at each concentration level. The results show that 365 
the calibration model developed from the Raman PhAT probe data had a higher accuracy 366 
than the UV-based model for the gel formulation (2 % (w/w) API). The UV method 367 
developed for the low-dosed suspension (0.09 % (w/w) API) had good performance 368 
characteristics, whereas the quantification of this low concentration was not possible with 369 
Raman spectroscopy due to detection sensitivity limitations. It was demonstrated that UV 370 
spectroscopy can be adopted as a novel PAT-tool for in-line and real-time quantification 371 
purposes during the manufacturing of pharmaceutical semi-solid and liquid formulations 372 
and that it can be complementary to other spectroscopic techniques, especially when the 373 
detection sensitivity is not sufficient. However, the feasibility of the spectroscopic 374 
technique is case dependent and should therefore be assessed in preliminary feasibility 375 
studies.  376 
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Table 1. Exposure time, number of scans, preprocessing methods, spectral region(s), R2, 






















 Gel (2 % w/w) Suspension (0.09 % w/w) 
UV Raman UV Raman 
Exposure time (s) 1 15 0.95 15 























R2 0.988 0.973 0.995 0.115 
Q2 0.988 0.973 0.995 0.028 
# of PLS 
components 
































Gel (2 % w/w) Suspension (0.09 % w/w) 
UV Raman UV Raman 
RMSECV (% w/w) 0.0274 0.0418 0.000819 0.0108 
RMSEP day 1 (% w/w) 0.0584 0.0255 0.00496 0.00947 
RMSEP day 2 (% w/w) 0.0709 0.0235 0.00148 0.00996 





Table 3. In-line UV and Raman quantification methods: validation parameters per 




















Gel (2 % w/w) 
UV 
1.75 -3.02 1.239 2.341 -11.14;5.10 
1.96 -0.88 0.838 2.652 -13.82;12.05 
2.06 -0.01 0.496 2.465 -12.21;12.19 
2.16 0.12 1.869 3.277 -11.56;11.80 
2.37 -1.05 1.040 2.226 -11.77;9.66 
Raman 
1.75 0.17 0.815 2.097 -10.12;10.46 
1.96 -0.48 1.127 1.225 -3.46;2.49 
2.06 -1.13 0.881 0.944 -3.36;1.10 
2.16 -0.97 0.627 0.815 -3.23;1.29 
2.37 -0.89 0.726 1.051 -4.07;2.30 
Suspension (0.09 % w/w) 
UV 
0.0774 3.04 0.752 4.479 -19.83;25.91 
0.0865 1.40 0.411 1.376 -5.47;8.28 
0.0910 0.65 0.417 1.653 -7.57;8.86 
0.0955 -0.92 0.508 1.848 -9.95;8.11 
0.1046 -4.05 0.785 4.501 -25.44;17.35 
Raman 
0.0772 16.06 2.425 3.035 6.72;25.40 
0.0862 4.90 1.437 1.437 1.40;8.40 
0.0908 0.28 1.653 2.910 -10.11;10.67 
0.0953 -4.08 2.429 2.429 -9.49;1.32 





Table 4. In-line UV and Raman quantification methods: estimates of the measurement 




level (% w/w) 
Uncertainty of 










Gel (2 % w/w) 
UV 
1.75 0.0204 0.0447 0.0894 5.10 
1.96 0.0286 0.0588 0.1177 6.01 
2.06 0.0289 0.0584 0.1168 5.67 
2.16 0.0356 0.0794 0.1588 7.34 
2.37 0.0275 0.0590 0.1180 4.98 
Raman 
1.75 0.0200 0.0418 0.0837 4.78 
1.96 0.0083 0.0252 0.0505 2.58 
2.06 0.0065 0.0203 0.0405 1.97 
2.16 0.0075 0.0190 0.0380 1.76 
2.37 0.0114 0.0271 0.0543 2.29 
Suspension (0.09 % w/w) 
UV 
0.0774 0.0020 0.0041 0.0082 10.63 
0.0865 0.0007 0.0014 0.0028 3.20 
0.0910 0.0009 0.0017 0.0035 3.82 
0.0955 0.0010 0.0020 0.0040 4.20 
0.1046 0.0026 0.0052 0.0104 9.94 
Raman 
0.0772 0.0011 0.0029 0.0059 7.63 
0.0862 0.0004 0.0014 0.0027 3.14 
0.0908 0.0013 0.0030 0.0059 6.53 
0.0953 0.0006 0.0023 0.0046 4.85 





Figure 1. Experimental setup: (a) customized mixing system without probes; (b) UV 












Figure 2. In-line UV spectra of the gel calibration batch between 280 - 300 nm (SNV and 
first derivative). Turquoise: 80 %, grey: 90 %, yellow: 95 %, black: 100 %, red: 105 %, 















Figure 3. In-line Raman spectra (SNV) of the gel calibration batch (blue) and off-line 













Figure 4. Detail of in-line Raman spectra (SNV and first derivative) of the gel calibration 
batch at the following spectral regions : (a) 385 – 407 cm-1, (b) 652 – 669 cm-1, (c) 1339 
– 1357 cm-1 and (d) 1575 – 1602 cm-1. Turquoise: 80 %, grey: 90 %, yellow: 95 %, black: 











Figure 5. Accuracy profiles of the (a) UV and (b) Raman in-line quantification methods for 
the gel. Plain black lines: acceptance limits set at 10 % (relative error), dashed blue lines: 











Figure 6. Accuracy profiles of the (a) UV and (b) Raman in-line quantification methods for 
the suspension. Plain black lines: acceptance limits set at 10 % (relative error), dashed 











Figure 7. Preprocessed in-line (a) UV and (b) Raman spectra of the suspension calibration 
batch. Turquoise: 80 %, grey: 90 %, yellow: 95 %, black: 100 %, red: 105 %, green: 110 
%, blue: 120 %.  
